Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves’ disease
Graves’ disease (GD) is an organ-specific autoimmune disease, and Thyrotropin (TSH) receptor (TSHR) is a major autoantigen in this condition. Since the extracellular domain of human TSHR (TSHR-ECD) is shed into the circulation, TSHR-ECD is a preferentially immunogenic portion of TSHR. Both genetic f...
Main Authors: | Hidefumi Inaba, Leslie J De Groot, Takashi Akamizu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-08-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fendo.2016.00120/full |
Similar Items
-
TSHR169 Antigen Specifically Binds to the Thyroid-stimulating Autoantibody, Representing an Effective Biomarker for Graves’ Disease
by: Zulkarnain Zulkarnain, et al.
Published: (2019-03-01) -
Is There Evidence for IGF1R-Stimulating Abs in Graves’ Orbitopathy Pathogenesis?
by: Christine C. Krieger, et al.
Published: (2020-09-01) -
Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves’ Orbitopathy
by: Augustine George, et al.
Published: (2021-02-01) -
Bioassays for TSH receptor autoantibodies, from FRTL-5 cells to TSH receptor–LH/CG receptor chimeras: the contribution of Leonard D. Kohn
by: Cesidio Giuliani, et al.
Published: (2016-07-01) -
Humoral Alloimmunity in Transplantation: Relevance of HLA Epitope Antigenicity and Immunogenicity
by: Rene J Duquesnoy
Published: (2011-11-01)